Alkermes plc. Interest Payable, Current
Alkermes plc. (ALKS) had Interest Payable, Current of $934.00 thousand as of 2013-09-30, per its 10-Q filed 2013-10-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2013-10-31
- 2013-09-30: Interest Payable, Current $934.00K.
- 2013-06-30: Interest Payable, Current $939.00K.
- 2013-03-31: Interest Payable, Current $970.00K.
- 2012-12-31: Interest Payable, Current $1.31M.
| Period end | Interest Payable, Current |
|---|---|
| 2013-09-30 | $934.00K 10-Q · filed 2013-10-31 |
| 2013-06-30 | $939.00K 10-Q · filed 2013-07-25 |
| 2013-03-31 | $970.00K 10-Q · filed 2013-10-31 |
| 2012-12-31 | $1.31M 10-Q · filed 2013-01-31 |
| 2012-09-30 | $275.00K 10-Q · filed 2012-11-01 |
| 2012-06-30 | $2.46M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $2.47M 10-K · filed 2013-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |